Breaking News
Get 40% Off 0
🚨 Volatile Markets? Find Hidden Gems for Serious Outperformance
Find Stocks Now
Close

Asymchem Laboratories Tian Jin Co Ltd (002821)

Create Alert
New!
Create Alert
Website
  • As an alert notification
  • To use this feature, make sure you are signed-in to your account
Mobile App
  • To use this feature, make sure you are signed-in to your account
  • Make sure you are signed-in with the same user profile

Condition

Frequency

Once
%

Frequency

Frequency

Delivery Method

Status

Add to/Remove from Watchlist Add to Watchlist
Add to Watchlist
Add Position

Position added successfully to:

Please name your holdings portfolio
 
84.18 +3.19    +3.94%
02:57:00 - Closed. Currency in CNY ( Disclaimer )
Type:  Equity
Market:  China
ISIN:  CNE100002BZ6 
  • Volume: 6,936,100
  • Bid/Ask: 84.18 / 84.18
  • Day's Range: 81.40 - 84.83
Asymchem Laboratories Tian Jin 84.18 +3.19 +3.94%

Asymchem Laboratories Tian Jin Co Ltd Company Profile

 
Get an in-depth profile of Asymchem Laboratories Tian Jin Co Ltd, including a general overview of the company's business and key management, as well as employee data and location and contact information.
IndustryPharmaceuticals
SectorHealthcare
Employees

9719

Equity Type

ORD

Asymchem Laboratories (Tianjin) Co., Ltd. engages in the provision of contract development and manufacturing services focuses on innovation and commercial application of global pharmaceutical technology in Mainland China and internationally. The company offers research and development, and production services for pharmaceutical and biotech companies. Its solutions range from early clinical stage to commercial stage, including research and development, and cGMP production of advanced intermediates, active pharmaceutical ingredients, and formulations, as well as clinical research services. The company also engages in the provision of pharmaceutical analysis and testing services; information technology services; and pharmaceutical science and technology development activities, as well as sale, wholesale, and retail of drugs. In addition, it is involved in the manufacture, development, and sale of medicine raw materials and relevant products; manufacture of chemical products; and technology development activities. The company was founded in 1999 and is headquartered in Tianjin, China.

Contact Information

Address No. 6 Dongting 3rd Street Economic-Technological Development Area
Tianjin,
China
Phone -
Fax -

Top Executives

Name Age Since Title
Da Zhang 41 2018 CFO, Senior VP & Executive Director
Rui Yang 44 2011 Co-CEO & Executive Director
Liang Hong 49 2011 Executive VP & Executive Director
Hao Hong 67 2011 Founder, Chairman & CEO
Xinxin Zhi 43 2011 Chairman of the Supervisory Committee
Kar Chung Lee 42 2021 Independent Non Executive Director
Ye Song 63 2011 Non-Executive Director
Shanshan Di 37 2017 Shareholder representative Supervisor
Jingyi Hou 40 2021 Employee Representative Supervisor
Stephane Caron - - Member of Scientific Advisory Board
Scott May - - Member of Scientific Advisory Board
Timothy F. Jamison - - Member of Scientific Advisory Board
Ting Zhang 38 2021 Non-Executive Director
Patricia Alred - - Member of Scientific Advisory Board
Jin-Quan Yu - - Member of Scientific Advisory Board
Nicholas Turner - - Member of Scientific Advisory Board
Martin Eastgate - - Member of Scientific Advisory Board
Seble Wagaw - - Member of Scientific Advisory Board
Stephen L. Buchwald - - Member of Scientific Advisory Board
Phil S. Baran 47 - Member of Scientific Advisory Board
Xuejiao Sun 41 2023 Independent Non-Executive Director
Xinyi Hou 62 2024 Independent Non-Executive Director
Comment Guidelines

We encourage you to use comments to engage with other users, share your perspective and ask questions of authors and each other. However, in order to maintain the high level of discourse we’ve all come to value and expect, please keep the following criteria in mind:  

  •            Enrich the conversation, don’t trash it.

  •           Stay focused and on track. Only post material that’s relevant to the topic being discussed. 

  •           Be respectful. Even negative opinions can be framed positively and diplomatically. Avoid profanity, slander or personal attacks directed at an author or another user. Racism, sexism and other forms of discrimination will not be tolerated.

  • Use standard writing style. Include punctuation and upper and lower cases. Comments that are written in all caps and contain excessive use of symbols will be removed.
  • NOTE: Spam and/or promotional messages and comments containing links will be removed. Phone numbers, email addresses, links to personal or business websites, Skype/Telegram/WhatsApp etc. addresses (including links to groups) will also be removed; self-promotional material or business-related solicitations or PR (ie, contact me for signals/advice etc.), and/or any other comment that contains personal contact specifcs or advertising will be removed as well. In addition, any of the above-mentioned violations may result in suspension of your account.
  • Doxxing. We do not allow any sharing of private or personal contact or other information about any individual or organization. This will result in immediate suspension of the commentor and his or her account.
  • Don’t monopolize the conversation. We appreciate passion and conviction, but we also strongly believe in giving everyone a chance to air their point of view. Therefore, in addition to civil interaction, we expect commenters to offer their opinions succinctly and thoughtfully, but not so repeatedly that others are annoyed or offended. If we receive complaints about individuals who take over a thread or forum, we reserve the right to ban them from the site, without recourse.
  • Only English comments will be allowed.
  • Any comment you publish, together with your investing.com profile, will be public on investing.com and may be indexed and available through third party search engines, such as Google.

Perpetrators of spam or abuse will be deleted from the site and prohibited from future registration at Investing.com’s discretion.

002821 Comments

Write your thoughts about Asymchem Laboratories Tian Jin Co Ltd
 
Are you sure you want to delete this chart?
 
Post
Post also to:
 
Replace the attached chart with a new chart ?
1000
Your ability to comment is currently suspended due to negative user reports. Your status will be reviewed by our moderators.
Please wait a minute before you try to comment again.
Thanks for your comment. Please note that all comments are pending until approved by our moderators. It may therefore take some time before it appears on our website.
 
Are you sure you want to delete this chart?
 
Post
 
Replace the attached chart with a new chart ?
1000
Your ability to comment is currently suspended due to negative user reports. Your status will be reviewed by our moderators.
Please wait a minute before you try to comment again.
Add Chart to Comment
Confirm Block

Are you sure you want to block %USER_NAME%?

By doing so, you and %USER_NAME% will not be able to see any of each other's Investing.com's posts.

%USER_NAME% was successfully added to your Block List

Since you’ve just unblocked this person, you must wait 48 hours before renewing the block.

Report this comment

I feel that this comment is:

Comment flagged

Thank You!

Your report has been sent to our moderators for review
Continue with Google
or
Sign up with Email